Verastem Oncology
VSTM
#6412
Rank
HK$6.07 B
Marketcap
HK$80.65
Share price
-2.26%
Change (1 day)
97.41%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2025 (TTM): -HK$1.88 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are HK$13.37 Million. In 2024 the company made an earning of -HK$1.02 Billion a decrease over its 2023 earnings that were of -HK$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$1.88 Billion84.66%
2024 -HK$1.02 Billion49.31%
2023 -HK$0.69 Billion18.36%
2022 -HK$0.58 Billion3.67%
2021 -HK$0.56 Billion5.43%
2020 -HK$0.53 Billion-54.74%
2019 -HK$1.17 Billion105.99%
2018 -HK$0.57 Billion6.83%
2017 -HK$0.53 Billion86.06%
2016 -HK$0.29 Billion-37.03%
2015 -HK$0.46 Billion8.43%
2014 -HK$0.42 Billion29.52%
2013 -HK$0.33 Billion28.6%
2012 -HK$0.25 Billion133.9%
2011 -HK$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-HK$0.26 Billion-86.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.26 B-5,019.45%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$10.37 B-653.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$72.57 B-3,969.69%๐Ÿ‡ฌ๐Ÿ‡ง UK